Objective: To assess the prevalence of allergic rhinitis and the factors associated with the use of emergency care services by children and adolescents with acute asthma submitted to inhaled corticosteroid therapy.
Introduction
Asthma and allergic rhinitis (AR) are manifestations of united airway disease. 1, 2 The medical literature has shown that AR is found in 75 to 80% of asthmatic patients. 3, 4 Emergency care services account for only 1% of direct costs related to AR, but for 62% of expenses on asthma management. 5, 6 Clinical observation and literature data demonstrate that an adequate approach to upper airway inflammation is paramount to the successful management of asthmatic patients. 1, 2 It is common knowledge that the association between asthma and AR results in a larger prescription of asthma drugs, higher costs, and wider use of health services. 7, 8 Moreover, the need of emergency care services due to exacerbations of asthma indicates poor management of asthma among patients treated with prophylactic drugs. 9 In our review of the literature, we did not find any Brazilian studies on the impact of AR on emergency care services in asthmatic patients treated with inhaled corticosteroids.
The aim of the present study is to assess the prevalence of AR in asthmatic patients treated at a referral outpatient
At Campos Sales outpatient clinic, a personalized action plan, which includes an educational approach, is used as one of the treatment mainstays, and patients receive an ID card with all detailed information about the prophylactic treatment and action plan. 
Statistical analysis
First of all, independent variables and their association with the dependent variable (emergency care services in the third year of treatment) were assessed by the odds ratio, using a 95% confidence interval.
Thereafter, all the variables with a p ≤ 0.20 in the univariate analysis were added to the logistic regression model. The preliminary model included age range, classification of asthma severity, presence or absence of AR and number of exacerbations.
The exclusion of each variable was determined by Wald's test, and the models were compared using the likelihood ratio.
The final model was adjusted by Hosmer-Lemeshow statistic.
The significance level was set as p < 0.05.
Ethical aspects
The study protocol was approved by the Research Ethics
Committee of Universidade Federal de Minas Gerais, Brazil.
Results
In 2005, 861 patients were submitted to beclomethasone dipropionate therapy: 576 for less than 3 years and 285 for ≥ 3 years, which means that only 126 patients were eligible.
The general characteristics of the study population are shown in Table 1 .
Most children were male and their median age was 99.2 months. AR was observed in 74.6% of the children. None of the patients was referred by basic health services to the outpatient clinic with a prior diagnosis of AR. Table 2 shows the distribution of patients according to the presence or absence of AR.
Note that the patients did not show statistically significant differences in terms of gender, age range, asthma severity and duration of disease. However, patients with AR had higher beclomethasone compliance rates than those without AR ( Table 3 ).
Note that 44 patients had exacerbations that required emergency care. The presence of AR virtually tripled the necessity for emergency care. Table 4 shows the final model for emergency care services in the third year of inhaled corticosteroid therapy.
Te presence of AR and asthma severity was regarded as independent factor for the necessity of emergency care. The number of exacerbations lost its statistical significance when adjusted for asthma severity, whereas age range lost its significance when adjusted for AR. The Hosmer-Lemeshow statistic yielded a value of 0.964, showing that the model was well adjusted. There was no interaction between the analyzed variables.
Discussion
The present study revealed that 74.6% of asthmatic children and adolescents developed concomitant AR, the presence of which, combined with asthma severity, was correlated with the necessity of emergency care. Allergic rhinitis and acute asthma -Lasmar LM et al.
Another study, also conducted at an outpatient clinic, involved 369 patients aged 3 to 16 years who had been followed up for 1 year at an asthma referral center, and showed that 68.8% of the patients had AR.
13
The follow-up of 747 children from their birth demonstrated that 42% developed concomitant asthma and AR at the age of 6 years, and that 50% of them presented with AR-compatible symptoms in the first year of life. The authors underscore the early onset of AR and its association with a higher frequency of respiratory symptoms at the age of 6 years. 14 Solé et al., in a population-based study, used ISAAC phase 3 questionnaire and found remarkable differences across the cities they analyzed. The largest prevalence rates of AR among school-aged children (39.8%) and adolescents (47.4%) were observed in Salvador and Belém, respectively. 15 Other studies show that AR coexists with asthma in 75 to 80% of asthmatic patients.
3,4
The percentage of patients with AR in the present study amounted to 74.6% (95%CI 65.9-81.7), which is in agreement with the rates described in the literature (38.9 to 80%).
The medical literature has pointed out that the fact that the diagnosis of AR based on clinical criteria worsens asthma management 16 is far more important than the association between asthma and AR. In outpatient-based studies, the prevalence of AR is higher than in population-based ones.
In the present study, all children participated in an asthma control program with regular follow-up visits and free-ofcharge dispensation of beclomethasone dipropionate. Nevertheless, 34.9% of them presented with acute asthma episodes, which therefore failed to be controlled.
The fact that none of the patients was referred to the out- The factors associated with emergency care services found in the present study were the presence of AR and asthma severity. These findings deserve some considerations. The first one concerns the fact that patient's attention is restricted to the use of inhaled corticosteroids only. Possibly, in some of these patients, the association of a long-acting bronchodilator may have reduced the number of acute asthma episodes, since 47.3% of the patients had severe persistent asthma. These patients were prescribed doses of 750 μg (500 to 1,000 μg)/day. They actually needed doses of 513.5 μg/day, which is regarded as the mean dose. In these cases, the literature recommends using a long-acting bronchodilator as an alternative option. 9 Another aspect that should be considered is that the stan- The data obtained herein are consistent with those described in the literature, which indicate that the control of asthma requires the management of asthma and AR with ascending drug therapies.
9,10
Cristal-Peters et al. conducted a historical cohort study using data from dispensaries and found out that patients treated for AR were 50% less likely to necessitate emergency The efficacy of the unified treatment for AR and asthma, which consists of the use of a dose-metered beclomethasone aerosol, inhaled through a face mask coupled to a large valved spacer, was confirmed and may be an alternative to the treatment of AR and asthma in public health programs. 19 The findings obtained here should be critically evaluated and the limitations of the study should be taken into account as well. This study was conducted at a referral outpatient clinic; therefore, its characteristics concern patients with moderate to severe asthma, but include those of patients referred by basic health services who are treated at the outpatient clinic on a regular basis. Patients with severe asthma are the ones who most often use health services, and in our patient population, the prevalence of AR might indicate a higher asthma severity.
The study design -cross-sectional in the third year of treatment -was due to the fact that some children were referred to the outpatient clinic at the age of 1 year. Given the difficulties in making the diagnosis of asthma and AR in this age group after 3 years of follow-up, the patients' medical records already indicated the diagnosis of both diseases.
On the other hand, cross-sectional studies only describe the association between events without defining the causality between them. Our study design does not allow us to infer that the poor management of asthma episodes resulted from the fact that patients were treated for AR using only dextrochlorpheniramine. To assess the impact of several AR treatments on emergency care services, clinical and placebocontrolled trials are necessary. Patients with AR needed higher doses of inhaled corticosteroids, and the presence of AR associated with asthma severity was an independent factor for the use of emergency care for the management of acute asthma.
The present study, in agreement with the guidelines established by ARIA, was based on clinical criteria for the diagnosis of AR. The possibility of a patient having received other drugs than beclomethasone and dextrochlorpheniramine from outside the dispensary system of the Wheezing Child Program is negligible. 20 We used the dispensary system to calculate compliance rates, which is a useful method for detecting patients with partial compliance that offers a great potential for the assessment of compliance rates in the public health system. 21, 22 In conclusion, the findings of the present study reveal a high prevalence of AR among patients with moderate to severe persistent asthma treated at a referral outpatient clinic. The factors associated with the use of emergency care were the presence of AR and asthma severity. The results point to the necessity of detecting AR as early as possible in asthmatic patients and of offering other therapies for the treatment of AR and asthma in public health programs. These measures would ensure better quality of care, optimize asthma control and reduce costs.
